Search Results

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex ® Scoring Balloon.

Cardiovascular Systems, Inc. has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral Orbital Atherectomy Systems (OAS) outside the United States and Japan.

Introducing a new portfolio of heart valve products aiming to restore health and extend life

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced that the full line of OrbusNeich® JADE® percutaneous transluminal angioplasty over-the-wire balloon catheters is now available in the U.S.

DNA tests are backbone of the emerging personalized health industry. As research develops, scientists discover more and more information that could be derived from DNA beyond ancestry.

Introduction of Orbital Atherectomy in the Middle East by OrbusNeich® Expands Treatment Options for Patients with Complex Coronary Artery Disease

This procedure marks the first international coronary procedure taking place as a result of the company’s distribution agreement with OrbusNeich®.

CSI is now the exclusive U.S. distributor of OrbusNeich balloon products.

Device is the smallest, 510(k) cleared coronary balloon in the U.S. market